Business Type: |
Manufacturer |
Year Established: |
2002 |
Industry Focus: |
Pharmaceutical Intermediates |
Products/Services We Offer: |
Potassium Clavulanate£¬ Potassium Clavulanate with Avicel 1:1£¬ Potassium Clavulanate with Avicel 7:3£¬ Potassium Clavulanate with Syloid 1:1£¬ Amoxycillin with Potassium Clavulanate 2:1£¬ Amoxycillin with Potassium Clavulanate 4:1£¬ Amoxycillin Sodium with Potassium Clavulanate 5:1
7ACA
Cefazolin Sodium for Injection 0.5g Cefazolin Sodium for Injection 0.5g Cefotaxime Sodium for Injection 1.0g Ceftriaxone Sodium for Injection 1.0g /2.0g Cefoperazone Sodium for Injection 1.0g Cefoperazone Sodium sulba |
Main Markets: |
China, India, Parkistan, Egypt, Korea |
Other Markets: |
Indonesia, Mexico, Uganda, Europe |
OEM Service: |
|
R&D Staff: |
5 - 10 People |
Legal Representative / CEO: |
Zhang Xiaochun |
Number of Employees: |
Above 1000 People |
Annual Turnover: |
US$5 Million - US$10 Million |
Certificate: |
|